Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into nine sections that are reviewed once a year. Each section is assigned one or two Section Editors, leading authorities in the area, who identify the most important topics at that time. Here we are pleased to introduce the Journal's Section Editor for this issue.
Roy M. Gulick
Dr Roy M. Gulick, MD, MPH is Rochelle Belfer Professor in Medicine and Chief of the Division of Infectious Diseases at Weill Cornell Medicine, USA, and Attending Physician at the New York Presbyterian Hospital in New York City, USA. He is board certified in internal medicine and infectious diseases.
Dr Gulick's research interests include designing, conducting and analyzing clinical trials to refine antiretroviral therapy strategies for HIV treatment and prevention, and assessing antiretroviral agents with new mechanisms of action. He currently serves as Principal Investigator of the Cornell-New Jersey HIV Clinical Trials Unit of the AIDS Clinical Trials Group (ACTG) and the HIV Prevention Trials Network (HPTN), sponsored by the US National Institutes of Health.
He also serves as the Co-Chair of the US Department of Health and Human Services (DHHS) Panel on Clinical Practices for Treatment of HIV Infection, a Member of the NIH Office of AIDS Research Advisory Committee (OARAC), a Board Member of the International Antiviral Society-USA, and previously served as a Member and as Chairman of the Antiviral Drugs Advisory Committee of the US Food and Drug Administration (FDA). He is a Member of the American Society of Clinical Investigation, the Association of American Physicians, the International AIDS Society, and the Infectious Diseases Society of America, and has presented at national and international meetings and been published widely.